Skip to main content

Displaying 253 - 264 of 2378

Director Bailey Reports a Million-Dollar BHVN Buy

April 26, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider transaction on today’s list is a Form 4 filing by Biohaven Pharmaceutical Holding Company Ltd $BHVN director Gregory Bailey.

Bailey bought 25,503 BHVN shares, equivalent to $999,169.

All Star Charts Premium

Junior International Hall of Famers (04-25-2024)

April 25, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The Junior International Hall of Famers.

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US-listed international stocks, or ADRs.

This scan is composed of the next 100 largest stocks by market cap, those that come after the top 100 and are thus covered by the International Hall of Famers universe.

Many of these names will someday graduate and join our original International Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

Let's dive right in and check out what these future big boys are up to.

This is our Junior International Hall of Famers list:

Director Bill Rhodes Buys 50,000 RF Shares

April 25, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The only insider transaction on today’s list is a Form 4 filing by William C. Rhodes.

Rhodes reported the acquisition of 50,000 shares of Regions Financial Corporation $RF at a total cost of approximately $1 million.

All Star Charts Premium, 2 to 100 Club

2 to 100 Club (04-24-2024)

April 25, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

As most of you know, we use various bottom-up tools and scans to complement our top-down approach.

It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

Atlas Venture Buys 17,857 KRRO Shares

April 24, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list is a Form 4 filing by Atlas Venture Opportunity Fund.

The hedge fund reported the acquisition of 17,857 shares of Korro Bio Inc $KRRO, equivalent to roughly $1 million.

Cormorant Reports a $10.4 Million EYPT Purchase

April 23, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list is a Form 4 filing by Cormorant Asset Management LP.

The hedge fund reported a purchase of $10.4 million in EyePoint Pharmaceuticals Inc $EYPT.

All Star Charts Premium

The Minor Leaguers (04-22-2024)

April 22, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The Minor Leaguers.

We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.

Farhad Nanji Reports a $24 Million RXO Buy

April 22, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list is a Form 4 filing by Farhad A. Nanji, founder of MFN Partners Management LP.

Nanji reported an additional purchase of $24 million in RXO Inc $RXO.

Failed Breakouts Everywhere

April 19, 2024

From the Desk of Alfonso Depablos @AlfCharts

2024 is far from being like 2023. 

While we’ve experienced some healthy sector rotation, the first quarter was characterized by waning momentum.

With these long-standing momentum divergences in place, so far, the second quarter has been characterized by selling pressure. 

Since last week, we’ve seen an increasing number of these divergences confirmed by price. 

Making matters worse is where this downside is taking place. We're also seeing a growing list of indexes and sectors lose key former highs.

Until the bulls can reclaim these polarity zones, markets will remain messy. 

Let’s talk about some of them.

All Star Charts Premium

The Hall of Famers (04-19-2024)

April 19, 2024

From the desk of Steve Strazza @Sstrazza

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. Click here to check it out.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

*Click table to enlarge view

Baker Bros Boosts Its BCYC Stake to 19.90%

April 19, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list is a 13D filing by Baker Bros Advisors LLC for Bicycle Therapeutics plc $BCYC.

Baker Bros revealed an increase in its ownership stake in BCYC from 12.70% to 19.90%.